Back to search

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

Data up to Jan 2025

Published2008
Citations826
References156

Total Citations Per Year

Abstract

References (156)

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1998 • 5,063 citations

Epidemiology of Parkinson's disease

2006 • 3,818 citations

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

2000 • 3,559 citations

Mitochondrial Membrane Permeabilization in Cell Death

2007 • 3,375 citations

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

2004 • 3,278 citations

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

2003 • 2,691 citations

Oxidative stress in Parkinson's disease

2003 • 2,001 citations

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

2000 • 1,975 citations

The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis

1999 • 1,872 citations

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

1989 • 1,717 citations

Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System

2000 • 1,628 citations

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

2006 • 1,489 citations

Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene

2000 • 1,398 citations

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

2002 • 1,178 citations

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

2005 • 1,172 citations

Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants

2003 • 1,156 citations

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

2004 • 1,091 citations

Abnormalities of the electron transport chain in idiopathic parkinson's disease

1989 • 1,067 citations

An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin

2001 • 1,048 citations

Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

2000 • 975 citations

Effects of Coenzyme Q10 in Early Parkinson Disease

2002 • 965 citations

Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice

2004 • 959 citations

Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons

2003 • 884 citations

‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease

2007 • 864 citations

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

2006 • 861 citations

DJ‐1 has a role in antioxidative stress to prevent cell death

2004 • 828 citations

Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

2002 • 760 citations

A common LRRK2 mutation in idiopathic Parkinson's disease

2005 • 758 citations

S -Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function

2004 • 750 citations

DJ-1, a Novel Oncogene Which Transforms Mouse NIH3T3 Cells in Cooperation withras

1997 • 736 citations

Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease

1989 • 735 citations

Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled

2006 • 703 citations

α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress

2000 • 694 citations

Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress

2005 • 676 citations

Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease

1990 • 676 citations

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

2006 • 648 citations

Origin and functional consequences of the complex I defect in Parkinson's disease

1996 • 629 citations

α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease

2005 • 600 citations

AnIn VitroModel of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage

2002 • 575 citations

DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation

2004 • 572 citations

Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP

2002 • 569 citations

Altered Proteasomal Function in Sporadic Parkinson's Disease

2002 • 565 citations

Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons

2007 • 561 citations

Mitochondrial disease

2006 • 557 citations

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

2005 • 554 citations

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

2003 • 543 citations

Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations

2005 • 535 citations

Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study

2004 • 535 citations

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

2004 • 531 citations

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

2005 • 520 citations

Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1

2005 • 518 citations

PINK1 mutations are associated with sporadic early‐onset parkinsonism

2004 • 480 citations

Lewy bodies and parkinsonism in families with parkin mutations

2001 • 479 citations

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1

2007 • 467 citations

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

2005 • 464 citations

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease

2004 • 454 citations

Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients

1993 • 449 citations

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

2005 • 448 citations

Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism

2005 • 442 citations

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

1995 • 430 citations

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

2006 • 426 citations

Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons

1996 • 422 citations

Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis

2005 • 418 citations

Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration

2005 • 412 citations

Genetic and environmental factors in the cause of Parkinson's disease

2003 • 383 citations

Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice

2004 • 383 citations

Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity

1999 • 372 citations

Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway

2001 • 365 citations

Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability

2005 • 363 citations

Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition

2003 • 358 citations

Platelet mitochondria function in Parkinson's disease

1992 • 350 citations

Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence

1990 • 345 citations

BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

1992 • 341 citations

Early-onset parkinsonism associated with PINK1 mutations

2005 • 335 citations

PINK1 protein in normal human brain and Parkinson's disease

2006 • 328 citations

Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system

2006 • 325 citations

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

2003 • 323 citations

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

1998 • 313 citations

DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor

2001 • 312 citations

Mitochondrial involvement in Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia and Friedreich’s ataxia

1999 • 309 citations

Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage

2005 • 304 citations

How much phenotypic variation can be attributed to parkin genotype?

2003 • 291 citations

Novel pharmacological targets for the treatment of Parkinson's disease

2006 • 290 citations

Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients

1999 • 274 citations

Parkin enhances mitochondrial biogenesis in proliferating cells

2006 • 261 citations

Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease

2003 • 259 citations

The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis

2005 • 246 citations

Lewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers

2005 • 242 citations

Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe

2003 • 242 citations

Complex I, Iron, and ferritin in Parkinson's disease substantia nigra

1994 • 239 citations

Early‐onset familial parkinsonism due to POLG mutations

2006 • 232 citations

Novel PINK1 mutations in early-onset parkinsonism

2005 • 226 citations

Biochemical and pathological characterization of Lrrk2

2006 • 223 citations

Identification of Mitochondrial DNA Polymorphisms That Alter Mitochondrial Matrix pH and Intracellular Calcium Dynamics

2006 • 219 citations

Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease

2006 • 215 citations

Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations

2003 • 212 citations

An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in theparkin gene

2000 • 209 citations

A randomized clinical trial of coenzyme Q 10 and GPI-1485 in early Parkinson disease

2007 • 208 citations

Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study

2002 • 201 citations

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

1994 • 201 citations

Mice lacking alpha-synuclein are resistant to mitochondrial toxins

2005 • 201 citations

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

2000 • 198 citations

Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease

2003 • 196 citations

Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q10 in Parkinson Disease

2007 • 195 citations

Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial

2006 • 194 citations

Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease

2004 • 193 citations

Clinical features ofLRRK2-associated Parkinson's disease in central Norway

2005 • 186 citations

Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD

2005 • 179 citations

TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial

2006 • 176 citations

A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy

2000 • 173 citations

A heterozygous effect for PINK1 mutations in Parkinson's disease?

2006 • 163 citations

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

2005 • 162 citations

Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress

2006 • 161 citations

Inhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease

2006 • 153 citations

LRRK2 mutations in Parkinson disease

2005 • 152 citations

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline

2006 • 149 citations

A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations

2005 • 149 citations

Point mutations of mitochondrial genome in Parkinson's disease

1995 • 147 citations

Treatment Options in the Modern Management of Parkinson Disease

2007 • 139 citations

Clinical Spectrum of Homozygous and Heterozygous PINK1 Mutations in a Large German Family With Parkinson Disease

2006 • 136 citations

Parkin is associated with cellular vesicles

2001 • 132 citations

Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism

2004 • 129 citations

Pesticide Exposure Exacerbates α-Synucleinopathy in an A53T Transgenic Mouse Model

2007 • 128 citations

Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease

1991 • 123 citations

An out-of-frame cytochromeb gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production

2000 • 118 citations

Clinical and Genetic Heterogeneity in Progressive External Ophthalmoplegia Due to Mutations in Polymerase γ

2003 • 115 citations

Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity

2004 • 114 citations

Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins

1998 • 112 citations

mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish

2003 • 111 citations

Mitochondrial ND5 mutations in idiopathic Parkinson’s disease

2004 • 111 citations

Mitochondrial DNA analysis in Parkinson's disease

1990 • 109 citations

PINK1 mutations in sporadic early‐onset Parkinson's disease

2006 • 99 citations

The dardarin G2019S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases

2005 • 97 citations

Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function.

1993 • 95 citations

A Novel Polymerase γ Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism

2004 • 94 citations

Parkin expression in the adult mouse brain

2000 • 92 citations

Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases

1986 • 92 citations

Oxidative stress in Parkinson's disease

1995 • 87 citations

Mutation of the Linker Region of the Polymerase γ-1 (POLG1Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism

2007 • 82 citations

Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle

1995 • 79 citations

Sequence Analysis of the Entire Mitochondrial Genome in Parkinson's Disease

2002 • 78 citations

Smoking and mitochondrial function: a model for environmental toxins

1993 • 74 citations

BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential

2003 • 66 citations

A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease

1994 • 62 citations

Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase

2006 • 51 citations

Novel mitochondrial DNA mutations in Parkinson's disease

2002 • 46 citations

The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism

2004 • 43 citations

Analysis of the trinucleotide CAG repeat from the DNA polymerase γ gene (POLG) in patients with Parkinson's disease

2004 • 42 citations

Genetic association study of PINK1 coding polymorphisms in Parkinson's disease

2004 • 32 citations

Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis

2007 • 31 citations

G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage

2004 • 30 citations

The Importance of LRRK2 Mutations in Parkinson Disease

2006 • 30 citations

Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease

2007 • 28 citations

Parkinson disease: analysis of mitochondrial DNA in monozygotic twins.

2000 • 22 citations

Absence of the Mitochondrial A7237T Mutation in Parkinson′s Disease

1995 • 20 citations

Parkinson disease: analysis of mitochondrial DNA in monozygotic twins

2000 • 17 citations

Cited By (0)

Loading...
Mitochondria in the aetiology and pathogenesis of Parkinson's disease (2008) – The Lancet Neurology | Metascience Observatory Explorer